Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Park Ha Biological Technology Co's accounts receivables for the quarter that ended in Apr. 2026 was $0.02 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Park Ha Biological Technology Co's Days Sales Outstanding for the quarter that ended in Apr. 2026 was 2.47.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Park Ha Biological Technology Co's Net-Net Working Capital per share for the quarter that ended in Apr. 2026 was $5.92.
Park Ha Biological Technology Co Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Park Ha Biological Technology Co's Days Sales Outstanding for the quarter that ended in Apr. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Park Ha Biological Technology Co's accounts receivable are only considered to be worth 75% of book value:
Park Ha Biological Technology Co's Net-Net Working Capital Per Share for the quarter that ended in Apr. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Park Ha Biological Technology Co Accounts Receivable Related Terms
Park Ha Biological Technology Co Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Ha Biological Technology Co Accounts Receivable Chart
What does a Accounts Receivable of $0.02 Mil mean?
Park Ha Biological Technology Co (BYAH) has a Accounts Receivable of $0.02 Mil as of Apr. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Park Ha Biological Technology Co and its competitors.
Is Park Ha Biological Technology Co's Accounts Receivable too high?
Park Ha Biological Technology Co's current Accounts Receivable is $0.02 Mil. Overall, Park Ha Biological Technology Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Ha Biological Technology Co's Accounts Receivable compare to CAWW and NASO?
Park Ha Biological Technology Co's Accounts Receivable of $0.02 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Consumer Packaged Goods company?
A good Accounts Receivable depends on the Consumer Packaged Goods industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Park Ha Biological Technology Co and its competitors. Park Ha Biological Technology Co's current Accounts Receivable is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Ha Biological Technology Co stock overvalued right now?
Park Ha Biological Technology Co (BYAH) has a current Accounts Receivable of $0.02 Mil. The current Accounts Receivable is $0.02 Mil. Park Ha Biological Technology Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Park Ha Biological Technology Co (BYAH), the current Accounts Receivable is $0.02 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
20GF Score
Get the complete analysis for BYAH
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BYAH has been successfully added to your 
